Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients: A Multicenter, Randomized, Open-Label Trial

NCT07715929 is registered in ClinicalTrials.gov with Yunlong Wang as lead sponsor.

NCT NCT07715929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07715929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients: A Multicenter, Randomized, Open-Label Trial
Lead sponsor
Yunlong Wang
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
December 30, 2029
Enrollment
710 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, catheter ablation, obesity & overweight